Phaarmasia Balance Sheet Annual

BSE: 523620 | NSE: - | ISIN: INE486I01016 | Sector: Biotechnology & Drugs

48.44 +1.05 (2.22%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.15	0.14	0.13	0.13
Cash Equivalents	0.49	0.55	0.08	0.26
Cashand Short Term Investments	0.63	0.69	0.22	0.38
Accounts Receivable- Trade Net	8.05	7.51	3.19	4.27
Total Receivables Net	8.05	7.51	3.19	4.27
Total Inventory	8.50	6.36	4.24	2.63
Other Current Assets Total	0.79	0.49	0.65	1.31
Total Current Assets	17.97	15.04	8.30	8.59
Property/ Plant/ Equipment Total- Net	12.44	12.75	12.73	13.02
Intangibles Net	0.03	0.03	0.03	0.03
Long Term Investments	0.05	0.05	0.14	0.26
Other Long Term Assets Total	0.95	0.54	-	-
Total Assets	31.45	28.42	21.21	21.91
Accounts Payable	20.08	16.54	8.13	6.65
Current Portof LT Debt/ Capital Leases	0.13	0.12	0.01	0.02
Other Currentliabilities Total	0.70	0.62	0.72	1.19
Total Current Liabilities	20.91	17.28	8.86	7.87
Long Term Debt	0.00	0.00	0.02	0.03
Capital Lease Obligations	0.01	0.14	-	-
Total Long Term Debt	0.01	0.14	0.02	0.03
Total Debt	0.14	0.27	0.03	0.05
Deferred Income Tax	0.00	0.00	0.11	0.14
Other Liabilities Total	0.22	0.18	0.15	0.22
Total Liabilities	21.15	17.61	9.15	8.26
Common Stock Total	6.83	6.83	6.83	6.83
Retained Earnings( Accumulated Deficit)	3.47	-	-	-
Total Equity	10.30	10.81	12.06	13.65
Total Liabilities Shareholders' Equity	31.45	28.42	21.21	21.91
Total Common Shares Outstanding	0.00	0.00	0.00	0.00
Notes Payable/ Short Term Debt	-	0.00	0.00	0.00
Other Equity Total	-	3.98	5.23	6.83